Abstract
Purpose of Review
It is vitally important that providers treating post-traumatic stress disorder continue to stay abreast of research advances in the treatment of this disorder. This article updates the reader about advances in research in PTSD treatment in the past four years as well as the evolving recommendations of clinical practice guidelines.
Recent Findings
One of the most important developments is that trauma-focused therapy (TFT) has emerged as the first-line treatment for PTSD with pharmacologic options often being noted as second-line or adjunctive.
Summary
The quality and quantity of research into the treatment of PTSD continue to grow; however, the pace of research into treatment options lags behind our understanding of the development, course, and prognosis of the disorder. The development of new research-based evidence in the treatment of PTSD, both pharmacologic and psychotherapeutic, is needed and likely to necessitate frequent updates and re-evaluations of clinical practice guidelines.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Post-traumatic stress disorder in the National Comorbidity Survey. Gen Psychiatry. 1995;52:1048–60.
Prigerson, Holly G, Maciejewski, Paul K, Rosenheck, Robert A. Population attributable fractions of psychiatric disorders and behavioral outcomes associated with combat exposure among US men. Am J Public Health 2002; 92(1):59–63. https://doi.org/10.2105/AJPH.92.1.59.
Dohrenwend BP, Turner JB, Turse NA, Adams BG, Koenen KC, Marshall R. The psychological risks of Vietnam for U.S. veterans: a revisit with new data and methods. Science. 2006;313(5789):979–82. https://doi.org/10.1126/science.1128944.
Moore BA, Penk WE. PTSD in the military. In: Moore BA, Penk WE, editors. Treating PTSD in military personnel: a clinical handbook. New York: Guilford; 2019. p. 2–3.
Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence. 2007. Washington, DC: National Academies Press.
•• Department of Veterans Affairs and Department of Defense (VA/DoD). VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder. Washington, DC: Author; 2017. This document outlines detailed recommendations for the pharmacological and psychosocial treatments of PTSD in veterans and military personnel and is based on research available at the time and expert consensus.
Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986;99(1):20–35. https://doi.org/10.1037/0033-2909.99.1.20.
Resick PA, Schnicke MK. Cognitive processing therapy for sexual assault victims. J Consult Clin Psychol. 1992;60(5):748–56. https://doi.org/10.1037/0022-006X.60.5.748.
Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314:489–500. https://doi.org/10.1001/jama.2015.8370.
• Steenkamp MM, Litz BT, Marmar CR. First-line psychotherapies for military-related PTSD. JAMA. 2020. (online ahead of print). https://doi.org/10.1001/jama.2019.20825. This article is the latest in a series of articles highlighting the limitations of evidence-based therapies for PTSD to include lack of efficacy and high dropout rates.
Charney ME, Hellberg SN, Bui E, Simon NM. Evidenced-based treatment of posttraumatic stress disorder: an updated review of validated psychotherapeutic and pharmacological approaches. Harvard Review of Psychiatry. 2018;26(3):99–115. https://doi.org/10.1097/HRP.0000000000000186.
American Psychological Association. Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. Washington DC: Author; 2017.
International Society for Traumatic Stress Studies (ISTSS). ISTSS PTSD prevention and treatment guidelines: methodology and recommendation. 2018. Retrieved from http://istss.org/getattachment/TreatingTrauma/New-ISTSS-Prevention-and-Treatment-Guidelines/ISTSS_PreventionTreatmentGuidelines_FNL-March-19-2019.pdf.aspx.
•• National Institute for Health and Care Excellence (NICE). Guideline for post-traumatic stress disorder. London. United Kingdom: National Institute for Health and Clinical Practice. 2018. Retrieved from https://www.nice.org.uk/guidance/NG116. This document highlights the research available at the time that supports the use of psychotherapy as a first-line intervention for PTSD.
Phoenix Australia Center for Posttraumatic Mental Health. Australian guidelines for the prevention and treatment of acute stress disorder, posttraumatic stress disorder and complex PTSD. Melbourne, Australia: Author; 2020.
Hamblen JL, Norman SB, Sonis JH, Phelps AJ, Bisson JI, Nunes VD, et al. Guide to guidelines for the treatment of posttraumatic stress disorder in adults: an update. Psychotherapy. 2019;56:359–73. https://doi.org/10.1037/pst0000231.
Phoenix Australia Centre for Posttraumatic Mental Health. Australian guidelines for the treatment of acute stress disorder and post-traumatic stress disorder. Melbourne, Australia: Author; 2013.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016;33(9):792–806. https://doi.org/10.1002/da.22511.
Gu W, Wang C, Li Z, Wang Z, Zhang X. Pharmacotherapies for posttraumatic stress disorder: a meta-analysis. J Nerv Ment Dis. 2016;204:331–8. https://doi.org/10.1097/NMD.0000000000000478.
Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, et al. Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2017;48:1975–84. https://doi.org/10.1017/S003329171700349X.
Haung Z-D, Zhao Y-F, Li S, Gu H-Y, Lin L-L, Yang Z-Y, et al. Comparative efficacy and acceptability of pharmaceutical management of adults with post-traumatic stress disorder: a systematic review and meta-analysis. Front Pharmacol. 2020;559(11):1–17. https://doi.org/10.3389/fphar.2020.00599.
Sonis J, Cook JM. Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: a systematic review and meta-analysis. Psychiatry Res. 2019;282(December 2019 112637):1–8. https://doi.org/10.1016/j.psychres.2019.112637.
U.S. Department of Veterans Affairs National Center for PTSD. PTSD treatment decision aid: the choice is yours. https//www.ptsd.va.gov/apps/decisionaid/. Accessed August 29, 2020.
Management of Post-traumatic Stress Working Group. VA/DoD clinical practice guideline for management of post-traumatic stress disorder. 2010. Washington, D.C.: U.S. Department of Veterans Affairs and U.S. Department of Defense, October 2010.
Hepner KA, Farris C, Farmer CM, Iyiewuare PO, Tanielian T, Wilks A, et al. Delivering clinical practice guideline-concordant care for PTSD and major depression in military treatment facilities. Santa Monica, CA: RAND; 2017.
•• Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378(6):406–517. https://doi.org/10.1056/NEJMoa1507598. This articles challenges the long held notion that prazosin is an effective pharmacological treatment for PTSD-related nightmares.
Ehret M. Treatment of posttraumatic stress disorder: focus on pharmacotherapy. Mental health clinician [Internet]. 2019;9(6):373–82. https://doi.org/10.9740/mhc.2019.11.373.
Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018;319(4):354–64. https://doi.org/10.1001/jama.2017.21242.
Bryan CJ, Leifker FR, Rozek DC, Bryan AO, Reynolds ML, Oakey DN, et al. Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: results of a pilot, open-label, prospective cohort trial. J Clin Psychol. 2018 Dec;74(12):2070–81.
Hurley EC. Effective treatment of veterans with PTSD: comparison between intensive daily and weekly EMDR approaches. Frontiers Psychol. 2018;9:1458.
McLay RN, Webb-Murphy JA, Fesperman SF, Delaney EM, Gerard SK, Roesch SC, et al. Outcomes from eye movement desensitization and reprocessing in active-duty service members with posttraumatic stress disorder. Psychol Traum. 2016;8(6):702–8.
Resick PA, Wachen JS, Dondanville KA, Pruiksma KE, Yarvis JS, Peterson AL, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017;74(1):28–36. https://doi.org/10.1001/jamapsychiatry.2016.2729.
Holder N, Holliday R, Williams R, Mullen K, Surís A. A preliminary examination of the role of psychotherapist fidelity on outcomes of cognitive processing therapy during an RCT for military sexual trauma-related PTSD. Cogn Behav Ther. 2018;47(1):76–89.
Kendall PC, Gosch E, Furr JM, Sood E. Flexibility within fidelity. J Am Acad Child Adolesc Psychiat. 2008;47(9):987–93.
Waltman SH, Sokol L, Beck AT. Cognitive behavior therapy treatment fidelity in clinical trials: review of recommendations. Curr Psychiatr Rev. 2017 Dec 1;13(4):311–5.
Beidel DC, Frueh BC, Neer SM, Lejuez CW. The efficacy of trauma management therapy: a controlled pilot investigation of a three-week intensive outpatient program for combat-related PTSD. Journal of Anxiety Disorders. 2017;50:23–32.
Beidel DC, Frueh BC, Neer SM, Bowers CA, Trachik B, Uhde TW, et al. Trauma management therapy with virtual-reality augmented exposure therapy for combat-related PTSD: a randomized controlled trial. Journal of anxiety disorders. 2019 Jan 1;61:64–74.
Reger GM, Koenen-Woods P, Zetocha K, Smolenski DJ, Holloway KM, Rothbaum BO, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consul Clin Psychol. 2016;84(11):946.
Sloan DM, Marx BP, Lee DJ, Resick PA. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018;75(3):233–9. https://doi.org/10.1001/jamapsychiatry.2017.4249.
Thompson-Hollands J, Marx BP, Lee DJ, Resick PA, Sloan DM. Long-term treatment gains of a brief exposure-based treatment for PTSD. Depress anxiety. 2018 Oct;35(10):985–91.
King AP, Block SR, Sripada RK, Rauch SA, Porter KE, Favorite TK, et al. A pilot study of mindfulness-based exposure therapy in OEF/OIF combat veterans with PTSD: altered medial frontal cortex and amygdala responses in social–emotional processing. Front Psychiatry. 2016;7:154.
Nidich S, Mills PJ, Rainforth M, Heppner P, Schneider RH, Rosenthal NE, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec 1;5(12):975–86.
Tuerk PW, Rauch SA, Rothbaum BO. Effect size matters: a key neglected indicator of comparative trial quality. Lancet Psychiatry. 2019 Feb 1;6(2):e4.
Rutt BT, Oehlert ME, Krieshok TS, Lichtenberg JW. Effectiveness of cognitive processing therapy and prolonged exposure in the Department of Veterans Affairs. Psychol Rep. 2018 Apr;121(2):282–302.
Jacobson NS, Truax P. Clinical significance: a statistical approach to denning meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychologv. 1991;59(1):12–9.
Waltman SH, Landry JM, Pujol LA, Moore BA. Delivering evidence-based practices via telepsychology: illustrative case series from military treatment facilities. Prof Psychol Res Pract. 2020 Jun;51(3):205–13.
Acierno R, Gros DF, Ruggiero KJ, Hernandez-Tejada MA, Knapp RG, Lejuez CW, et al. Behavioral activation and therapeutic exposure for posttraumatic stress disorder: a noninferiority trial of treatment delivered in person versus home-based telehealth. Depress Anxiety. 2016;33(5):415–23.
Acierno R, Knapp R, Tuerk P, Gilmore AK, Lejuez C, Ruggiero K, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017 Feb 1;89:57–65.
• Liu L, Thorp SR, Moreno L, Wells SY, Glassman LH, Busch AC, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. Journal of Telemedicine and Telecare. 2019:1357633X19853947. This article reviews the growing practice of providing evidence-based interventions for PTSD via technological means to include benefits and limitations.
Ford JD, Grasso DJ, Greene CA, Slivinsky M, DeViva JC. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641–9.
Waits W, Marumoto M, Weaver J. Accelerated resolution therapy (ART): a review and research to date. Curr Psychiatry Rep. 2017;19(3):18.
Kip KE, Rosenzweig L, Hernandez DF, Shuman A, Sullivan KL, Long CJ, et al. Randomized controlled trial of accelerated resolution therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013;178(12):1298–309.
Peterson AL, Foa EB, Resick PA, Hoyt TV, Straud CL, Moore BA, et al. A nonrandomized trial of prolonged exposure and cognitive processing therapy for combat-related posttraumatic stress disorder in a deployed setting. Behavior Therapy. 2020.
Thorp SR, Glassman LH, Wells SY, Walter KH, Gebhardt H, Twamley E, et al. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. Journal of anxiety disorders. 2019;64:45–54.
Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Santa Ana E, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019;90:369–77.
Najavits LM, Krinsley K, Waring ME, Gallagher MW, Skidmore C. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Substance use & misuse. 2018;53(11):1788–800.
Capone C, Presseau C, Saunders E, Eaton E, Hamblen J, McGovern M. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cogn Ther Res. 2018 Dec 1;42(6):735–46.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer: The views expressed in this article are those of the authors and do not reflect official policy or position of the Department of the Army, the Department of Defense, the US Government, or any of the institutional affiliations noted.
This article is part of the Topical Collection on Military Mental Health
Rights and permissions
About this article
Cite this article
Moore, B.A., Pujol, L., Waltman, S. et al. Management of Post-traumatic Stress Disorder in Veterans and Military Service Members: A Review of Pharmacologic and Psychotherapeutic Interventions Since 2016. Curr Psychiatry Rep 23, 9 (2021). https://doi.org/10.1007/s11920-020-01220-w
Accepted:
Published:
DOI: https://doi.org/10.1007/s11920-020-01220-w